The design of a novel class of potassium channel activating drugs, 2-(2,2-dimethylbenzopyran-4-yl)-pyridine-1-oxides
- 31 December 1991
- journal article
- Published by Elsevier in Life Sciences
- Vol. 48 (8) , 803-810
- https://doi.org/10.1016/0024-3205(91)90096-t
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Synthesis and antihypertensive activity of 4-(substituted-carbonylamino)-2H-1-benzopyransJournal of Medicinal Chemistry, 1990
- Evaluation of the bronchodilator properties of Ro 31–6930, a novel potassium channel opener, in the guinea‐pigBritish Journal of Pharmacology, 1990
- Conformational analysis of the novel antihypertensive agent cromakalim (BRL34915)Journal of the Chemical Society, Chemical Communications, 1989
- Complex heterocyclic structures ‐ a challenge for computer‐assisted molecular modelingBulletin des Sociétés Chimiques Belges, 1988
- New class of antihypertensive acts by opening K+ channelsTrends in Pharmacological Sciences, 1987
- Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyransJournal of Medicinal Chemistry, 1986
- Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal veinBritish Journal of Pharmacology, 1986
- IMPORTANT CONCEPTS OF RECEPTOR THEORYJournal of Autonomic Pharmacology, 1982